|
Cholecalciferol
|
Derivative of 7-dehydroxycholesterol formed by ultraviolet rays breaking of the C9-C10 bond. It differs from ergocalciferol in having a single bond between C22 and C23 and lacking a methyl group at C24. (PubChem) Pharmacology: Cholecalciferol (vitamin D3) is a steroid hormone that has long been known for its important role in regulating body levels of calcium and phosphorus, in mineralization of bone, and for the assimilation of Vitamin A. The classical manifestations of vitamin D deficiency is rickets, which is seen in children and results in bony deformaties including bowed long bones. Deficiency in adults leads to the disease osteomalacia. Both rickets and osteomalacia reflect impaired mineralization of newly synthesized bone matrix, and usually result from a combination of inadequate exposure to sunlight and decreased dietary intake of vitamin D. Common causes of vitamin D deficiency include genetic defects in the vitamin D receptor, severe liver or kidney disease, and insufficient exposure to sunlight. Vitamin D plays an important role in maintaining calcium balance and in the regulation of parathyroid hormone (PTH). It promotes renal reabsorption of calcium, increases intestinal absorption of calcium and phosphorus, and increases calcium and phosphorus mobilization from bone to plasma. Mechanism of action: The first step involved in the activation of vitamin D3 is a 25-hydroxylation which is catalysed by the 25-hydroxylase in the liver and then by other enzymes. The mitochondrial sterol 27-hydroxylase catalyses the first reaction in the oxidation of the side chain of sterol intermediates. The active form of vitamin D3 (calcitriol) binds to intracellular receptors that then function as transcription factors to modulate gene expression. Like the receptors for other steroid hormones and thyroid hormones, the vitamin D receptor has hormone-binding and DNA-binding domains. The vitamin D receptor forms a complex with another intracellular receptor, the retinoid-X receptor, and that heterodimer is what binds to DNA. In most cases studied, the effect is to activate transcription, but situations are also known in which vitamin D suppresses transcription. Calcitriol increases the serum calcium concentrations by: increasing GI absorption of phosphorus and calcium, increasing osteoclastic resorption, and increasing distal renal tubular reabsorption of calcium. Calcitriol appears to promote intestinal absorption of calcium through binding to the vitamin D receptor in the mucosal cytoplasm of the intestine. Subsequently, calcium is absorbed through formation of a calcium-binding protein. Drug type: Approved. Nutraceutical. Small Molecule. Drug category: Antihypocalcemic Agents. Antihypoparathyroid Agents. Bone Density Conservation Agents. Essential Vitamin. Vitamins. Vitamins (Vitamin D)
|
ILX:0102123
|
3
|
scicrunch
|
06/18/2018
|
scicrunch |
term |
12/08/2016 |
0 |
NeuroLex |
NeuroLex |
|
Cholecystokinin
|
|
ILX:0102124
|
3
|
scicrunch
|
06/18/2018
|
scicrunch |
term |
12/08/2016 |
0 |
NeuroLex |
NeuroLex |
|
Cholecystokinin receptor
|
|
ILX:0102125
|
3
|
scicrunch
|
06/18/2018
|
scicrunch |
term |
12/08/2016 |
0 |
NeuroLex |
NeuroLex |
|
Cholera toxin B-chain
|
A protein complex secreted by the bacterium Vibrio cholerae, comprising an oligomeric complex made up of six protein subunits: a single copy of the A subunit (part A, enzymatic), and five copies of the B subunit (part B, receptor binding), denoted as AB5. Cholera toxin acts by the B subunit ring of the cholera toxin binding to GM1 gangliosides on the surface of target cells. Once bound, the entire toxin complex is endocytosed by the cell and the cholera toxin A1 (CTA1) chain is released by the reduction of a disulfide bridge. (adapted from Wikipedia: http://en.wikipedia.org/wiki/Cholera_toxin)
|
ILX:0102126
|
3
|
scicrunch
|
06/18/2018
|
scicrunch |
term |
12/08/2016 |
0 |
NeuroLex |
NeuroLex |
|
Cholic
|
|
ILX:0102127
|
3
|
scicrunch
|
06/18/2018
|
scicrunch |
term |
12/08/2016 |
0 |
NeuroLex |
NeuroLex |
|
Choline
|
A basic constituent of lecithin that is found in many plants and animal organs. It is important as a precursor of acetylcholine, as a methyl donor in various metabolic processes, and in lipid metabolism. (PubChem) Pharmacology: This compound is needed for good nerve conduction throughout the CNS (central nervous system) as it is a precursor to acetylcholine (ACh). Choline is also needed for gallbladder regulation, liver function and lecithin (a key lipid) formation. Choline also aids in fat and cholesterol metabolism and prevents excessive fat build up in the liver. Choline has been used to mitigate the effects of Parkinsonism and tardive dyskinesia. Choline deficiencies may result in excessive build-up of fat in the liver, high blood pressure, gastric ulcers, kidney and liver dysfunction and stunted growth. Mechanism of action: Choline is a major part of the polar head group of phosphatidylcholine. Phosphatidylcholine's role in the maintenance of cell membrane integrity is vital to all of the basic biological processes: information flow, intracellular communication and bioenergetics. Inadequate choline intake would negatively affect all these processes. Choline is also a major part of another membrane phospholipid, sphingomyelin, also important for the maintenance of cell structure and function. It is noteworthy and not surprising that choline deficiency in cell culture causes apoptosis or programmed cell death. This appears to be due to abnormalities in cell membrane phosphatidylcholine content and an increase in ceramide, a precursor, as well as a metabolite, of sphingomyelin. Ceramide accumulation, which is caused by choline deficiency, appears to activate Caspase, a type of enzyme that mediates apoptosis. Betaine or trimethylglycine is derived from choline via an oxidation reaction. Betaine is one of the factors that maintains low levels of homocysteine by resynthesizing L-methionine from homocysteine. Elevated homocysteine levels are a significant risk factor for atherosclerosis, as well as other cardiovascular and neurological disorders. Acetylcholine is one of the major neurotransmitters and requires choline for its synthesis. Adequate acetylcholine levels in the brain are believed to be protective against certain types of dementia, including Alzheimer's disease. Drug type: Approved. Nutraceutical. Small Molecule. Drug category: Dietary supplement. Lipotropic Agents. Micronutrient. Nootropic Agents
|
ILX:0102128
|
5
|
scicrunch
|
08/24/2018
|
scicrunch |
term |
12/08/2016 |
0 |
NeuroLex |
troy sincomb |
|
Choline Acetyltransferase
|
A synthetic enzyme that catalyzes the formation of acetylcholine from acetyl-CoA and choline. EC 2.3.1.6 (MSH).
|
ILX:0102129
|
4
|
scicrunch
|
06/18/2018
|
scicrunch |
term |
12/08/2016 |
0 |
NeuroLex |
NeuroLex |
|
Cholinergic agonist role
|
Role of a molecule that has an affinity for and stimulates physiologic activity at cell receptors normally stimulated by acetylcholine (modified from http://medical-dictionary.thefreedictionary.com/cholinergic+agonist+(2))
|
ILX:0102130
|
3
|
scicrunch
|
06/18/2018
|
scicrunch |
term |
12/08/2016 |
0 |
NeuroLex |
NeuroLex |
|
Cholinergic neuron (FBbt Term)
|
Any neuron (FBbt_00005106) that releases as a neurotransmitter, some acetylcholine (CHEBI:15355).
|
ILX:0102131
|
3
|
scicrunch
|
06/18/2018
|
scicrunch |
term |
12/08/2016 |
0 |
NeuroLex |
NeuroLex |
|
Cholinergic receptor, nicotinic, alpha 5
|
A protein that is a translation product of the CHRNA5 gene or a 1:1 ortholog thereof. Nicotinic acetylcholine receptors (nAChRs), such as CHRNA5, are members of a superfamily of ligand-gated ion channels that mediate fast signal transmission at synapses. The nAChRs are thought to be (hetero)pentamers composed of homologous subunits. See MIM 118508 for additional background information on AChRs.(adapted from OMIM).
|
ILX:0102132
|
7
|
scicrunch
|
10/24/2018
|
scicrunch |
term |
12/08/2016 |
0 |
NeuroLex |
troy sincomb |
|
Cholinergic system
|
any molecule, protein, cell, tissue or organ that is related to acetylcholine.
|
ILX:0102133
|
5
|
scicrunch
|
06/23/2020
|
scicrunch |
term |
12/08/2016 |
0 |
NeuroLex |
NeuroLex |
|
Chondroitin sulfate proteoglycan
|
|
ILX:0102134
|
3
|
scicrunch
|
06/18/2018
|
scicrunch |
term |
12/08/2016 |
0 |
NeuroLex |
NeuroLex |
|
Chordata
|
|
ILX:0102135
|
5
|
scicrunch
|
06/18/2018
|
scicrunch |
term |
12/08/2016 |
0 |
NeuroLex |
NeuroLex |
|
Chordin
|
A protein that is a translation product of the CHRD gene or a 1:1 ortholog thereof. Chordin regulates signaling by BMP pathway. (PRO:CNA)
|
ILX:0102136
|
7
|
scicrunch
|
10/24/2018
|
scicrunch |
term |
12/08/2016 |
0 |
NeuroLex |
troy sincomb |
|
Chordoma
|
A notochordal cancer that derives_from cellular remnants of the notochord.
|
ILX:0102137
|
4
|
scicrunch
|
08/19/2021
|
scicrunch |
term |
12/08/2016 |
0 |
NeuroLex |
NeuroLex |
|
Chorea
|
Involuntary, forcible, rapid, jerky movements that may be subtle or become confluent, markedly altering normal patterns of movement. Hypotonia and pendular reflexes are often associated. Conditions which feature recurrent or persistent episodes of chorea as a primary manifestation of disease are referred to as CHOREATIC DISORDERS. Chorea is also a frequent manifestation of BASAL GANGLIA DISEASES (MeSH).
|
ILX:0102138
|
3
|
scicrunch
|
06/18/2018
|
scicrunch |
term |
12/08/2016 |
0 |
NeuroLex |
NeuroLex |
|
Choriogonadotropin alfa
|
Recombinant human chorionic gonadotropin with 2 subunits, alpha
|
ILX:0102139
|
3
|
scicrunch
|
06/18/2018
|
scicrunch |
term |
12/08/2016 |
0 |
NeuroLex |
NeuroLex |
|
Chorionic gonadotropin
|
|
ILX:0102140
|
3
|
scicrunch
|
06/18/2018
|
scicrunch |
term |
12/08/2016 |
0 |
NeuroLex |
NeuroLex |
|
Choroid Epithelial Cell
|
Cuboidal shaped epithelial cell forming one of the components of the choroid plexus (Peters, Palay and Webster, 1991).
|
ILX:0102141
|
4
|
scicrunch
|
06/18/2018
|
scicrunch |
term |
12/08/2016 |
0 |
NeuroLex |
NeuroLex |
|
Choroid plexus
|
a structure consisting of modified ependymal cells in the ventricles of the brain responsible for the production of cerebral spinal fluid (CSFF).
|
ILX:0102142
|
8
|
scicrunch
|
06/23/2020
|
scicrunch |
term |
12/08/2016 |
0 |
NeuroLex |
NeuroLex |